Optimization Of Lead Small Molecule Inhibitors Of Taspase1 For Cancer Therapeutics
US Application 62/939,258
Filed on 2019-11-22
Filed on 2019-11-22
PLK1 POLO BOX DOMAIN INHIBITOR AND METHOD OF TREATING CANCER
US Application 63/082,813
Filed on 2020-09-24
Filed on 2020-09-24
TYROSYL-LOCK PEPTIDES
US Application 63/115,418
Filed on 2020-11-18
Filed on 2020-11-18
RNASEH-ASSISTED DETECTION ASSAY FOR RNA (RADAR)
US Application 63/077,123
Filed on 2020-09-11
Filed on 2020-09-11
LZK-TARGETING DEGRADERS AND METHODS OF USE
US Application 63/073,835
Filed on 2020-09-02
Filed on 2020-09-02
Synthetic Lethality-mediated Precision Oncology Via The Tumor Transcriptome
US Application 63/107,737
Filed on 2020-10-30
Filed on 2020-10-30
HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12V MUTATION
US Application 63/060,340
Filed on 2020-08-03
Filed on 2020-08-03
HLA CLASS II-RESTRICTED DQ T CELL RECEPTORS AGAINST RAS WITH G13D MUTATION
US Application 63/086,674
Filed on 2020-10-02
Filed on 2020-10-02
Synthetic Self-assembling Peptide Antagonists Of Human CCR3 For The Treatment Of Inflammatory Diseases
US Application 62/117,486
Filed on 2015-02-18
Filed on 2015-02-18
TARGETING THE CHOLECYSTOKININ-B RECEPTOR FOR IMAGING AND EARLY DETECTION OF PANCREATIC CANCER AND PRE-CANCEROUS LESIONS
US Application 63/030,815
Filed on 2020-05-27
Filed on 2020-05-27